These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 29174957)

  • 1. Alternatives to Testosterone Therapy: A Review.
    Lo EM; Rodriguez KM; Pastuszak AW; Khera M
    Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Non-Testosterone-Based Treatment in Hypogonadal Men: A Review.
    Raheem OA; Chen T; Akula KP; Greenberg J; Le TV; Chernobylsky D; Sikka SC; Walsh TJ
    Sex Med Rev; 2021 Jul; 9(3):381-392. PubMed ID: 33933392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocytosis Following Testosterone Therapy.
    Ohlander SJ; Varghese B; Pastuszak AW
    Sex Med Rev; 2018 Jan; 6(1):77-85. PubMed ID: 28526632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Therapy for Male Hypogonadism.
    Carrasquillo R; Chu K; Ramasamy R
    Curr Urol Rep; 2018 Jun; 19(8):63. PubMed ID: 29886559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel androgen therapies including selective androgen receptor modulators.
    Kang J; Chen R; Tharakan T; Minhas S
    Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101686. PubMed ID: 35981955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Testosterone replacement therapy and cardiovascular risk].
    Corona G; Dicuio M; Rastrelli G; Sforza A; Maggi M
    G Ital Cardiol (Rome); 2017 Nov; 18(11):745-753. PubMed ID: 29105668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy.
    Ide V; Vanderschueren D; Antonio L
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
    Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
    J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
    Khera M; Miner M; Jaffe J; Pastuszak AW
    J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
    Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
    J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging medication for the treatment of male hypogonadism.
    Aydogdu A; Swerdloff RS
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in Testosterone Therapy.
    Twitchell DK; Pastuszak AW; Khera M
    Sex Med Rev; 2021 Jan; 9(1):149-159. PubMed ID: 33309270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone supplementation in men: a practical guide for the gynecologist and obstetrician.
    Owen RC; Elkelany OO; Kim ED
    Curr Opin Obstet Gynecol; 2015 Aug; 27(4):258-64. PubMed ID: 26107780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.
    Sigalos JT; Pastuszak AW; Khera M
    Med Clin North Am; 2018 Mar; 102(2):361-372. PubMed ID: 29406064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicocele Repair Versus Testosterone Therapy for Older Hypogonadal Men with Clinical Varicocele and Low Testosterone.
    Bernie HL; Goldstein M
    Eur Urol Focus; 2018 Apr; 4(3):314-316. PubMed ID: 30316825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.
    Traish AM
    Sex Med Rev; 2018 Jan; 6(1):86-105. PubMed ID: 29128268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism?
    Awouters M; Vanderschueren D; Antonio L
    Andrology; 2020 Nov; 8(6):1590-1597. PubMed ID: 31696669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
    Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
    Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
    Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
    J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
    Hackett G
    Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.